Cardiosolutions Inc. has raised $7 million in Series A funding led by BioVentures Investors. The Stoughton, Mass.-based company is developing a minimally-invasive system for repair of a regurgitant mitral valve interfering with normal heart function. www.cardiosolutionsinc.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.